Method for efficiently synthesizing L-alanine by coordinating metabolic pathway of escherichia coli
By knocking out the eutD gene, integrating the pyruvate-induced glucose metabolism system and inserting the DAS+4 degradation tag, the problem of by-product accumulation during E. coli fermentation is solved, the yield and conversion rate of L-alanine is improved, and high efficiency is achieved L-alanine production.
Patent Information
- Application Number
- CN202411077399.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-07
- Publication Date
- 2024-11-29
AI Technical Summary
In the prior art, by-products produced by recombinant E. coli during the fermentation process, such as acetic acid, pyruvate, etc., reduce the conversion rate of L-alanine and affect the efficiency of its industrial production.
By knocking out the phosphate transacetylase encoding gene eutD, pyruvate induction glucose metabolism system is integrated, and DAS+4 degradation tag is inserted after the pyruvate dehydrogenase complex lpdA gene, it regulates glucose metabolism and weakens TCA circulating flow, and reduces by-products The accumulation of L-alanine is increased.
It significantly reduced the synthesis of acetic acid, increased the production of L-alanine, reaching 195.2g/L, improved the conversion rate, and optimized the growth and fermentation conditions of bacteria, achieving efficient L-alanine production .
Smart Images

Figure CN119040230A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for efficiently synthesizing L-alanine by coordinating the metabolic pathway of Escherichia coli, and belongs to the field of bioengineering. Background Art
[0002] L-alanine is a non-essential amino acid and a food additive and nutritional supplement approved by the U.S. Food and Drug Administration. It is widely used in the healthcare industry and can also be used as a low-calorie sweetener and skin and hair care agent in cosmetics. In addition, L-alanine also has great application potential in the industrial field. Its most attractive use is as one of the important raw materials for the production of trisodium dicarboxymethylalanine (MGDA). MGDA is a new type of green chelating agent with excellent performance and is suitable for a variety of cleaning products. The reduction in the cost of L-alanine has greatly accelerated the development of MGDA. In addition, L-alanine also shows great potential in the production of biodegradable and biocompatible polymers (such as polyesteramides) and engineering thermoplastics (such as polyamides).
[0003] Escherichia coli has simple nutritional requirements, can be grown using cheap culture media and can easily obtain high-density cells, and has the advantages of short fermentation cycle, high fermentation yield and high production intensity. At the same time, E. coli has a clear genetic background and mature genetic engineering operations. Since L-alanine has a significant inhibitory effect on the growth and metabolism of Escherichia coli, excessively high concentrations of L-alanine will inhibit cell growth and product synthesis. The inventors previously developed a temperature control switch to allow the cell growth stage and the L-alanine fermentation stage to proceed step by step. The L-alanine yield reached 120.3 g / L and the sugar-acid conversion rate was 88.3% (Appl Biochem Biotechnol (2016) 178: 324–337). Through the optimization of fermentation conditions, the strain's maximum L-alanine yield reached 167.7 g / L (Method for synthesizing L-alanine by fermentation of recombinant Escherichia coli using different carbon sources, 2024106218418), which is currently the highest yield of L-alanine synthesized by Escherichia coli using inorganic salt culture medium. However, the strain produces a variety of organic acid byproducts during the fermentation process, such as pyruvic acid, acetic acid, lactic acid, etc. The production of these byproducts will reduce the conversion rate of fermentation synthesis of L-alanine. In order to achieve the industrial production of L-alanine and solve the problem of still high content of byproducts (especially acetic acid), it is urgent to further develop new strategies to improve the L-alanine synthesis performance of the recombinant strain. Summary of the invention
[0004] In response to the problem of by-product accumulation in the L-alanine synthesis process, the present invention provides a method for reducing by-product accumulation and increasing L-alanine production by exploring the by-product synthesis metabolic pathway, TCA cycle and the effects of glucose decomposition metabolites on L-alanine fermentation synthesis.
[0005] The present invention provides a recombinant Escherichia coli with improved L-alanine production capacity, which has at least one of the following improvements on the basis of the starting strain:
[0006] (1) Knock out the phosphotransacetylase encoding gene eutD to reduce the synthesis of byproduct acetic acid;
[0007] (2) Integrating the pyruvate-sensing glucose metabolism system into the gene mgsA on the chromosome to avoid excessive metabolism by dynamically regulating the glucose uptake pathway, thereby reducing the amount of organic acid byproduct synthesis; the pyruvate-sensing glucose metabolism system is pGEX-J23100-SdPdhR-J23101-F9-sgrT, which is disclosed in the paper "Metabolic engineering ofglycolysis in Escherichia coli for efficient production of patchoulol andτ-cadinol", and its nucleotide sequence is shown in SEQ ID NO.3;
[0008] (3) inserting a DAS+4 degradation tag after the pyruvate dehydrogenase complex gene lpdA to weaken the TCA cycle flow and increase the L-alanine conversion rate; the coding sequence of the DAS+4 degradation tag is shown in SEQ ID NO.2.
[0009] In one embodiment, the starting strain is Escherichia coli B0016-060BC, which has been disclosed in the paper "Efficient L-alanine production by a thermo-regulated switch in Escherichia coli".
[0010] In one embodiment, the nucleotide sequence of gene eutD is shown as Gene ID: 946940.
[0011] In one embodiment, the nucleotide sequence of gene mgsA is shown as Gene ID: 945574.
[0012] In one embodiment, the nucleotide sequence of gene lpdA is shown as Gene ID:944854.
[0013] The present invention also provides a method for increasing the production of L-alanine and reducing the production of acetic acid, wherein the method comprises performing at least one of the following improvements on a recombinant Escherichia coli having the ability to produce L-alanine:
[0014] (1) Reduce the expression of phosphotransacetylase;
[0015] (2) integrating the pyruvate-sensing glucose metabolism system into the chromosome mgsA; the pyruvate-sensing glucose metabolism system is pGEX-J23100-SdPdhR-J23101-F9-sgrT, which is disclosed in the paper "Metabolic engineering of glycolysis in Escherichia coli for efficient production of patchoulol and τ-cadinol", and its nucleotide sequence is shown in SEQ ID NO.3;
[0016] (3) inserting a DAS+4 degradation tag after the lpdA gene of the pyruvate dehydrogenase complex; the coding sequence of the DAS+4 degradation tag is shown in SEQ ID NO.2.
[0017] In one embodiment, reducing the expression of phosphotransacetylase includes but is not limited to knocking out the phosphotransacetylase encoding gene eutD.
[0018] In one embodiment, the recombinant Escherichia coli having the ability to produce L-alanine includes but is not limited to Escherichia coli B0016-060BC.
[0019] The present invention also provides a method for producing L-alanine using the recombinant Escherichia coli, which comprises subjecting the recombinant Escherichia coli to aerobic-oxygen-limited two-stage fermentation culture in an M9 medium containing glucose and ammonium sulfate.
[0020] In one embodiment, the "aerobic-oxygen-limited two-stage fermentation culture" is specifically: first culture in an aerobic environment at 32-34°C for a period of time, then raise the temperature to 40-42°C for static culture or continue fermentation until the end without supplying oxygen to the fermentation system.
[0021] In one embodiment, the fermentation temperature is controlled at 32-34°C during the aerobic fermentation stage and cultured until the OD 600 When the temperature reaches 3.0, it turns to the oxygen-limited fermentation stage; the oxygen-limited fermentation stage is statically cultured at 40-42° C., and glucose is also fed into the culture system during this stage.
[0022] In one embodiment, the fermentation temperature is controlled at 32-34°C and the dissolved oxygen is ≥45% during the aerobic fermentation stage, and the culture is carried out until the OD 600When the temperature reaches 50, the culture is continued at 40-42° C. for 40-50 min and then the fermentation is switched to the oxygen-limited fermentation stage; in the oxygen-limited fermentation stage, the air flux is adjusted to 0 and the fermentation temperature is 40-42° C. In this stage, glucose is also fed into the culture system and the glucose concentration is controlled to be ≥10 g / L.
[0023] The present invention also provides application of the recombinant Escherichia coli or the method in producing L-alanine or a product containing L-alanine.
[0024] Beneficial effects:
[0025] (1) The present invention significantly reduces the amount of acetic acid synthesized during the fermentation process of Escherichia coli by knocking out eutD, and the amount of acetic acid synthesized as a byproduct decreases by 25.3%.
[0026] (2) The present invention utilizes a pyruvate-sensing glucose metabolism control system to dynamically regulate the glucose metabolism process, effectively alleviating the excessive glucose metabolism. The accumulation of byproducts pyruvate, succinate, and lactic acid during the fermentation process is significantly reduced, and the L-alanine production is increased by 8.9% to 183 g / L.
[0027] (3) The present invention reduces the flux of pyruvate to the TCA cycle by inserting a DAS+4 self-degradation tag at the tail end of the lpdA gene of the pyruvate dehydrogenase complex, thereby reducing the oxygen demand during the bacterial growth stage and indirectly improving the activity of the bacteria in the oxygen-limited stage. The L-alanine production is further increased by 6.9% to 195.2 g / L. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 The present invention provides a metabolic modification strategy for synthesizing L-alanine.
[0029] Figure 2 To study the effect of knocking out the eutD gene on the synthesis of L-alanine and acetic acid in shake flask fermentation.
[0030] Figure 3 The effects of different pyruvate-sensing glucose metabolism regulatory systems on L-alanine fermentation synthesis. (A) Schematic diagram of the principle of pyruvate-sensing glucose metabolism regulatory system regulating L-alanine synthesis; (B) The effects of pyruvate-sensing glucose metabolism regulatory systems with different promoter combinations on L-alanine fermentation synthesis.
[0031] Figure 4 This is the L-alanine synthesis curve of strain B0016-080BC in a 5L fermenter.
[0032] Figure 5 This is a comparison chart of the oxygen demand for bacterial growth of B0016-090BC and B0016-080BC strains in a 5L fermenter.
[0033] Figure 6 This is the L-alanine synthesis curve of strain B0016-090BC in a 5L fermenter. DETAILED DESCRIPTION
[0034] (I) Culture medium
[0035] LB liquid culture medium: 10g / L sodium chloride, 5g / L yeast powder, 10g / L tryptone, and 20.0g / L agar powder should be added to prepare solid culture medium.
[0036] M9-1 culture medium: 1 g / L ammonium chloride, 3 g / L potassium dihydrogen phosphate, 6 g / L disodium hydrogen phosphate, 0.3 g / L sodium chloride, trace element solution 0.1% (v / v), 5 g / L glucose, 1 mmol / L magnesium sulfate, 13.2 g / L ammonium sulfate.
[0037] Trace element solution: measure MnSO4·4H2O 0.5g / L, (NH4)Mo7O 24 0.1g / L, FeSO4·7H2O 10.0g / L, CuSO4·5H2O 3.0g / L, ZnSO4·7H2O 5.25g / L, Na2B4O7·10H2O 0.2g / L, CaCl2 2.0g / L, prepared with 0.1mol / LHCl.
[0038] (II) Detection method:
[0039] L-alanine detection method: adjust the sample pH to 8.0 with NH4OH, dilute appropriately and then derivatize with phenylisothioate (PITC). The derivatization steps are as follows: add 250μL 0.1mol / L PITC acetonitrile solution and 250μL 1mol / L triethylamine acetonitrile solution to 500μL sample, mix thoroughly, place at room temperature for 1h away from light, add 700μL n-hexane solution, vortex oscillator for 1min, let stand for 5min, aspirate the lower layer solution, filter with 0.22μm organic filter membrane and perform high pressure liquid detection.
[0040] Organic acid detection method: (1) Sample treatment: Centrifuge the sample to be tested at 12000r / min for 2min, dilute the supernatant to an appropriate concentration, and filter to obtain the organic acid sample to be tested.
[0041] (2) High performance liquid chromatography (HPLC) determination conditions of organic acids: the chromatographic column was Suprsil C18 (250 mm × 4.6 mm, 5 μm), the mobile phase was potassium dihydrogen phosphate solution at pH 2.5 and 25 mmol / L, the flow rate was 1 mL / min; the column temperature was 40 °C, and the detection wavelength was 210 nm.
[0042] Glucose detection method: centrifuge the sample to be tested at 12000r / min for 2min, and retain the supernatant. Take 25μL of 1g / L glucose standard solution to calibrate the glucose concentration meter. After the instrument shows that the calibration is successful, add 25μL of the sample to be tested into the detector. The reading displayed on the instrument multiplied by the dilution factor of the test solution is the glucose content in the fermentation liquid to be tested.
[0043] Example 1: Knockout of phosphotransacetylase eutD reduces the synthesis of acetic acid byproducts
[0044] (1) Construction of strain B0016-070BC:
[0045] Although the previous study has knocked out multiple byproducts in strain B0016-060BC (disclosed in the paper "Efficient L-alanine production by athermo-regulated switch in Escherichia coli"), the accumulation of acetic acid in the 5L fermenter can still reach 5g / L (Table 3). In order to further reduce the synthesis of acetic acid and improve the conversion rate of L-alanine, the present embodiment first knocks out the phosphotransacetylase gene eutD (Gene ID: 946940) of strain B0016-060BC to construct strain B0016-070BC. The construction process is as follows:
[0046] ① Using pST plasmid (nucleotide sequence as shown in SEQ ID NO.1) as a template, SacB-SF-eutd and tet-r-eutd primers were used to amplify the targeting fragment containing the homology arm of the eutD gene and the SacB-tet gene.
[0047] ② Streak strain B0016-060BC on a non-antibiotic plate, pick a single colony after culturing for 8 hours and inoculate it into LB liquid medium at 200 r·min -1 , after culturing at 37°C for 10-12h, transfer 1% (v / v) bacterial solution to another LB medium and rotate at 200 r·min -1 , cultured at 37°C until OD 600 0.6, after precooling at 4℃ for 30min, 12000r·min -1 The cells were collected by centrifugation for 10 min.
[0048] ③ Resuspend the cells with low-temperature sterile ultrapure water, 12000r·min -1 , centrifuge at 4°C, remove the supernatant, and repeat this operation four times to prepare competent cells required for electrotransfection.
[0049] ④ Add 1 μL of plasmid pKD46 to the 99 μL competent cells prepared above, mix thoroughly and add to the electroporation cup. After electroporation at 1800 V for 5 ms, immediately add LB liquid medium and rotate at 200 r·min. -1 , culture at 30℃ for 60-90min. Apply an appropriate amount of bacterial solution on a solid culture medium containing ampicillin antibiotics and culture at 30℃.
[0050] ⑤Inoculate a single colony in LB medium with ampicillin and rotate at 200 r·min -1 , culture at 30℃ for 10-12h, transfer 1% (v / v) bacterial solution to another LB medium, and rotate at 200r·min -1 , cultured at 30°C until OD 600 0.6, after precooling at 4℃ for 30min, 12000r·min -1 Centrifuge for 10 min to collect the cells and repeat step ③.
[0051] ⑥ Add 30 μL of the targeting fragment prepared in step ① to the 70 μL competent cells prepared in step ⑤, mix thoroughly and add to the electroporation cup. After electroporation at 1800 V for 5 ms, immediately add LB liquid medium and rotate at 200 r·min. -1 , culture at 30℃ for 60-90min. Take an appropriate amount of bacterial solution and spread it on a solid culture medium containing tetracycline, and culture it at 30℃. Use eutDyz-f and eutdyz-r primers for colony PCR amplification, and agarose gel electrophoresis to verify that the 5816bp band is a successful integration colony.
[0052] ⑦ According to the location of the edited gene in the chromosome, a 90bp single-stranded targeting fragment ssDNA-eutD with 45bp on each side of eutD-SacB-tet in the genome of the recombinant strain was designed. The ssDNA is in the lagging strand during DNA replication.
[0053] ⑧ Prepare competent cells with the strain obtained in step ⑥ according to the methods of steps ② and ③, add 30 μL of the targeting fragment ssDNA-eutD prepared in step ⑦ to 70 μL of competent cells, mix well and add to the electroporation cup, immediately add LB liquid culture medium after electric shock at 1800V for 5ms, and culture at 200r / min and 30℃ for 60-90min. Take an appropriate amount of bacterial liquid and spread it on a solid culture medium containing 3mM / L NiCl2 and 10% (m / v) sucrose, and culture at 30℃.
[0054] ⑨Use eutDyz-f and eutdyz-r primers for colony PCR, and verify by agarose gel electrophoresis that the 1545 bp band is the strain B0016-070BC with successful integration.
[0055] Table 1 Primers used to construct strain B0016-070BC
[0056]
[0057] Note: “*” indicates thio modification.
[0058] (2) Effect of knocking out the eutD gene on the synthesis of byproduct acetic acid:
[0059] The E. coli eutD gene encodes a protein containing a phosphate acetyltransferase domain and is a more efficient phosphotransacetylase than that of E. coli (encoded by the pta gene) and is differentially regulated by the Pta effector to indirectly synthesize acetate.
[0060] The strain B0016-070BC and the strain B0016-060BC were fermented under the following conditions:
[0061] The strain was streaked on an LB plate and cultured for 24 hours. A single colony was inoculated into 50 mL LB liquid medium and cultured at 33°C and 200 r / min for 10 hours. The seed solution was inoculated at a 2% (v / v) inoculum into 50 mL M9-1 liquid medium containing 5 g / L glucose (in a 250 mL Erlenmeyer flask) for aerobic-oxygen-limited fermentation. The aerobic bacterial growth stage was cultured at 33°C and 200 r / min until OD 600 When the concentration of glucose reached 3.0, 1.5 mL of 500 g / L glucose and 2 g of CaCO3 were added in the oxygen-limited fermentation stage, and the culture was statically cultured at 42 °C. The fermentation was completed after 54 h in the two stages. Three parallel experiments were performed in each group.
[0062] The results showed that compared with the control strain B0016-060BC, the L-alanine production of strain B0016-070BC increased by 7.5%, and the amount of byproduct acetic acid synthesis decreased by 25.3% ( Figure 2 ).
[0063] Example 2: Dynamically regulating glucose metabolism to reduce byproduct synthesis
[0064] (1) Screening of pyruvate-sensing glucose metabolism regulation system:
[0065] The recombinant plasmids pGEX-J23100-SdPdhR-J23100-F9-sgrT, pGEX-J23101-SdPdhR-J23100-F9-sgrT, pGEX-J23100-SdPdhR-J23101-F9-sgrT, and pGEX-J23101-SdPdhR-J23101-F9-sgrT (published in the paper "Metabolic engineering of glycolysis in Escherichia coli for efficient production of patchoulol and τ-cadinol") containing the pyruvate-sensing glucose metabolism regulation system were transformed into the strain B0016-070BC constructed in Example 1, respectively, and the L-alanine synthesis levels of the four recombinant strains produced were compared.
[0066] Fermentation was carried out according to the method of Example 1. The results showed that ( Figure 3 B), the strain containing the pyruvate-sensing glucose metabolism regulation system of the J23100-J23101 promoter combination (present on the pGEX-J23100-SdPdhR-J23101-F9-sgrT plasmid) increased L-alanine production by 17.5% compared to the control strain.
[0067] (2) Construction of strain B0016-080BC:
[0068] The promoter combination of J23100-J23101 was used to integrate the pyruvate-sensing glucose metabolism regulation system (pGEX-J23100-SdPdhR-J23101-F9-sgrT) into the methylglyoxal synthase gene mgsA (Gene ID: 945574) in the B0016-070BC genome to construct strain B0016-080BC. The specific steps are as follows:
[0069] ① Amplify the target fragment pdhR-sgrT-SacB-tet containing 50bp homology arms on both sides of the upstream and downstream of the E.coil mgsA gene. Using the pGEX-J23100-SdPdhR-J23101-F9-sgrT plasmid as a template, sd-f2 and sgrt-r1 as upstream and downstream primers, the fragment pdhR-sgrT was amplified. Using the pST plasmid as a template, sacB-sgrT-f and tet-r1 as upstream and downstream primers, the sacB-tet gene fragment was amplified. The above two fragments were fused with sd-f2 and tet-r2 primers to amplify the target fragment pdhR-sgrT-sacB-tet with 50bp homology arms on both sides of the chromosome mgsA.
[0070] ② Streak the preserved B0016-070BC glycerol bacteria on a non-antibiotic plate, pick a single colony after culturing for 8 hours and inoculate it into LB liquid medium, culture it at 200 r / min and 37°C for 10-12 hours, then transfer 1% (v / v) bacterial solution to fresh LB medium, and culture it at 200 r / min and 37°C until OD 600 The concentration was 0.6. After precooling at 4°C for 30 min, the bacteria were collected by centrifugation at 12000 r / min for 10 min.
[0071] ③ Resuspend the cells with low-temperature sterile ultrapure water, centrifuge at 12000r / min and 4℃, remove the supernatant, and repeat this operation four times to prepare the competent cells required for electroporation.
[0072] ④ Add 1 μL of plasmid pKD46 to 99 μL of competent cells prepared in step ③, mix thoroughly and add to the electroporation cup, electroshock at 1800 V for 5 ms and immediately add LB liquid culture medium, culture at 200 r / min and 30°C for 60-90 min. Take an appropriate amount of bacterial liquid and spread it on the solid culture medium with ampicillin antibiotics and culture at 30°C.
[0073] ⑤ Inoculate a single colony in LB medium with ampicillin antibiotics, culture at 200 r / min and 30°C for 10 to 12 hours, then transfer 1% (v / v) bacterial solution to another LB medium and culture at 200 r / min and 30°C until OD 600 The concentration of the agarose gel was 0.6. After precooling at 4°C for 30 min, the cells were collected by centrifugation at 12000 r / min for 10 min and step ③ was repeated.
[0074] ⑥Add 30μL of the targeting fragment prepared in step ① to the 70μL competent bacteria prepared in step ⑤, mix thoroughly and add to the electroporation cup, electroshock at 1800V for 5ms and immediately add LB liquid culture medium, and culture at 200r / min and 30℃ for 60-90min. Take an appropriate amount of bacterial liquid and spread it on the solid culture medium with Tet antibiotics and culture at 30℃. Perform colony PCR with primers MgsA-yz-f and MgsA-yz-R, and verify that the 6236bp band obtained by agarose gel electrophoresis is the strain with successful integration.
[0075] ⑦ Repeat steps ② and ③ with the strain that successfully integrated the targeting fragment in step ⑥ to prepare competent cells.
[0076] ⑧ According to the location of the edited gene in the chromosome, design a 90bp single-stranded targeting fragment ssDNA-MgsA to remove 45bp on both sides of the chromosome genome fragment. The ssDNA should be in the lagging strand during DNA replication.
[0077] ⑨ Add 30 μL of the target fragment mgsA-ssDNA prepared in step ⑧ to 70 μL of the competent cells in step ⑦, mix thoroughly and add to the electroporation cup, electroshock at 1800 V for 5 ms and immediately add LB liquid culture medium, and culture at 200 r / min and 30°C for 60-90 min. Take an appropriate amount of bacterial liquid and spread it on a solid culture medium containing 3 mM / L NiCl2 and 10% (m / v) sucrose, and culture at 30°C.
[0078] ⑩ Colony PCR was performed on a single colony on the plate using primers MgsA-yz-f and MgsA-yz-R. Agarose gel electrophoresis was used to verify that the 2998 bp band was obtained, which was the strain with successful integration and was named B0016-080BC.
[0079] Table 2 Primers used to construct strain B0016-080BC
[0080]
[0081]
[0082] Note: “*” indicates thio modification.
[0083] (3) Shake flask fermentation of strain B0016-080BC:
[0084] Shake flask fermentation was carried out according to the method of Example 1. The results showed that ( Figure 3 B), the L-alanine production of strain B0016-080BC was increased by 10.9% compared with strain B0016-070BC.
[0085] (4) Strain B0016-080BC was fermented in a 5L fermenter:
[0086] Seed liquid culture method: The culture method of bacteria in LB plate and LB liquid culture medium is the same as the shake flask fermentation culture method. The first-level seed liquid is inoculated with 2% (v / v) inoculation volume into 150mL M9-1 liquid culture medium containing 5g / L glucose (in a 500mL Erlenmeyer flask), and cultured at 33°C, 200r / min shaking table for 9h. Fermentation tank inoculation method: The seed liquid is inoculated with 5% (v / v) inoculation volume into a 5L fermentation tank containing M9-1 culture medium. After inoculation, the initial volume of the fermentation liquid is 3L, and the initial concentration of glucose is 30g / L.
[0087] Aerobic stage culture: Initial air flux is 3L / min, stirring speed is 200r / min, dissolved oxygen concentration is set to 100%, air flux is adjusted to 7L / min during bacterial growth, stirring speed is linked to DO value to control dissolved oxygen concentration to always be ≥45%; NH4OH and 10% (v / v) H2SO4 are used to maintain pH 7.0; fermentation temperature is controlled at 33°C. When bacterial concentration reaches OD 600 When it reaches 50, the fermentation tank temperature is set to 42°C to continue aerobic culture for 45 minutes, and then enter the oxygen-limited fermentation and acid production stage.
[0088] Cultivation in oxygen-limited stage: air flux was adjusted to 0, stirring paddle speed was controlled at 100r / min, NH4OH was added to maintain pH at 7.0, fermentation temperature was 42°C, and glucose was added in batches at a concentration of 600g / L to maintain the residual sugar concentration of the fermentation liquid at not less than 10g / L during the fermentation process. Fermentation was terminated when all the added glucose was consumed or the fermentation tank stopped consuming sugar.
[0089] The results showed that after 60h of fermentation, the L-alanine production of strain B0016-080BC reached 183g / L, which was 9.1% higher than that of the starting strain B0016-060BC, and the conversion rate reached 86.5% ( Figure 4 ); the production intensity reached 3.07g / L / h after 60h of fermentation.
[0090] Table 3 Comparison of the amount of byproducts synthesized in 5L fermentation tanks
[0091]
[0092] The formation of acetate in Escherichia coli is the result of metabolic overflow, that is, excessive intake of carbon sources leads to accumulation of sugar metabolic pathways, forcing the production of excessive acetate. The usual solution is to reduce the content of free carbon sources in the environment, monitor the changes in the amount of residual sugar during the fermentation process, and adjust the feed rate in time. This method requires a large amount of work for fermentation production and has a low fault tolerance rate. The present invention enables Escherichia coli to spontaneously regulate the sugar uptake rate, effectively reduce the production of acetate, and increase the synthesis level of the target product L-alanine, providing a new idea for controlling metabolic overflow.
[0093] Example 3: Weakening pyruvate dehydrogenase to increase L-alanine production
[0094] (1) Construction of strain B0016-090BC:
[0095] ① Using pST plasmid as template and PDH-ST-F1 and PDH-ST-r as upstream and downstream primers, amplify the DAS+4-sacb-tet gene fragment (the nucleotide sequence is shown in SEQ ID NO.2); using DAS+4-Sacb-tet as template and PDH-ST-F2 and PDH-ST-r as upstream and downstream primers, amplify the DNA fragment with the homologous arms of the lpdA gene.
[0096] ② Streak the bacterial solution of strain B0016-080BC on a non-antibiotic plate, pick a single colony after culturing for 8 hours and inoculate it into LB liquid medium, culture it at 200r / min and 37℃ for 10-12 hours, then transfer 1% (v / v) bacterial solution to another LB medium, and culture it at 200r / min and 37℃ until OD 600 The concentration was 0.6. After precooling at 4°C for 30 min, the bacteria were collected by centrifugation at 12000 r / min for 10 min.
[0097] ③ Resuspend the cells with low-temperature sterile ultrapure water, centrifuge at 12000r / min and 4℃, remove the supernatant, and repeat this operation four times to prepare the competent cells required for electroporation.
[0098] ④ Add 1 μL of plasmid pKD46 to the 99 μL competent cells prepared in step ③, mix thoroughly and add to the electroporation cup, electroshock at 1800 V for 5 ms and immediately add LB liquid medium, and culture at 200 r / min and 30°C for 60-90 min. Take an appropriate amount of bacterial liquid and spread it on the solid culture medium with ampicillin and culture at 30°C.
[0099] ⑤ Inoculate a single colony in LB medium with ampicillin, culture at 200 r / min and 30°C for 10-12 hours, then transfer 1% (v / v) bacterial solution to another LB medium and culture at 200 r / min and 30°C until OD 600 The concentration of the agarose gel was 0.6. After precooling at 4°C for 30 min, the cells were collected by centrifugation at 12000 r / min for 10 min and step ③ was repeated.
[0100] ⑥ Add 30 μL of the targeting fragment prepared in step ① to the 70 μL competent bacteria prepared in step ⑤, mix thoroughly and add to the electroporation cup, add LB liquid culture medium immediately after electric shock at 1800V for 5ms, and culture at 200r / min and 30℃ for 60-90min. Take an appropriate amount of bacterial liquid and spread it on a solid culture medium with tetracycline and culture it at 30℃. Use pdh-yz-f1 and pdh-yz-r primers for colony PCR amplification, and run the gel to verify whether the targeting fragment is successfully integrated at the target site. The 3717bp band is the strain with successful integration.
[0101] ⑦ According to the location of the edited gene in the chromosome, a 90bp single-stranded targeting fragment ssDNA-PDH with 45bp on each side of sacB-tet in the genome of the recombinant strain was designed. The ssDNA is in the lagging strand during DNA replication.
[0102] ⑧ Prepare competent cells with the strain obtained in step ⑥ according to the methods of steps ② and ③, add 30 μL of the targeting fragment ssDNA-PDH prepared in step ⑦ to 70 μL of competent cells, mix well and add to the electroporation cup, immediately add LB liquid culture medium after electric shock at 1800V for 5ms, and culture at 200r / min and 30℃ for 60-90min. Take an appropriate amount of bacterial solution and spread it on a solid culture medium with 3mM / L NiCl2 and 10% (m / v) sucrose, and culture at 30℃.
[0103] ⑨Use pdh-yz-f2 and pdh-yz-r primers for colony PCR amplification, and verify by agarose gel electrophoresis that the 465bp band is the strain with successful integration, which is named B0016-090BC.
[0104] Table 4 Primers used to construct strain B0016-090BC
[0105]
[0106] Note: “*” indicates thio modification.
[0107] (2) Strain B0016-090BC was fermented in a 5L fermenter:
[0108] The fermentation conditions of reference embodiment 2 are applied to strain B0016-090BC for fermentation. In the early fermentation process, it is found that gas will be produced in the oxygen-limited stage, and some tricarboxylic acid cycle substances, such as succinic acid, fumaric acid, etc., will be detected. Therefore, it is speculated that although the production strain is in the oxygen-limited fermentation stage, some pyruvic acid is still converted into acetyl-CoA by the action of pyruvate dehydrogenase to enter the tricarboxylic acid cycle and release carbon dioxide. Endogenous protease ClpXP can recognize DAS+4 degradation tags, so after fusion expression of DAS+4 degradation tags with target protein, degradation of target protein will be accelerated, and the enzyme activity will be indirectly reduced. This study adds DAS+4 degradation tags at the end of the lpdA gene of pyruvate dehydrogenase to weaken its flux converted into acetyl-CoA, construct strain B0016-090BC, and improve the yield of L-alanine.
[0109] like Figure 5 As shown in Figure 2, after weakening the tricarboxylic acid cycle, the oxygen demand of strain B0016-090BC during the bacterial growth stage was significantly lower than that of strain B0016-080BC ( Figure 5), which can avoid the problem of limited oxygen supply inhibiting bacterial growth during large-scale fermentation production. After 60 hours of fermentation, the yield of strain B0016-090BC reached 195.2g / L, the total conversion rate was 88.6g / 100g glucose, and the production intensity reached 3.07g / L / h ( Figure 6 ), which is currently the highest level of L-alanine fermentation synthesized by recombinant Escherichia coli, and also the highest level of L-alanine fermentation synthesized by inorganic salt medium.
[0110] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. A recombinant Escherichia coli with improved L-alanine production capacity and reduced by-product accumulation, characterized in that: Based on the starting strain, there is at least one of the following improvements: (1) The phosphotransacetylase encoding gene eutD was knocked out; (2) integrating a pyruvate-sensing glucose metabolism system at the gene mgsA on the chromosome; the pyruvate-sensing glucose metabolism system is pGEX-J23100-SdPdhR-J23101-F9-sgrT, having a nucleotide sequence as shown in SEQ ID NO.3; (3) inserting a DAS+4 degradation tag after the pyruvate dehydrogenase complex gene lpdA; the coding sequence of the DAS+4 degradation tag is shown in SEQ ID NO.
2.
2. The recombinant Escherichia coli according to claim 1, characterized in that The starting strain is Escherichia coli B0016-060BC.
3. The recombinant Escherichia coli according to any one of claims 1 or 2, characterized in that The nucleotide sequence of gene eutD is shown in Gene ID: 946940; the nucleotide sequence of gene mgsA is shown in Gene ID: 945574; and the nucleotide sequence of gene lpdA is shown in Gene ID: 944854.
4. A method for increasing the production of L-alanine and reducing the production of acetic acid in Escherichia coli, characterized in that: The recombinant Escherichia coli having the ability to produce L-alanine is improved by at least one of the following: (1) Reduce the expression of phosphotransacetylase; (2) integrating the pyruvate-sensing glucose metabolism system into the gene mgsA on the chromosome; the pyruvate-sensing glucose metabolism system is pGEX-J23100-SdPdhR-J23101-F9-sgrT, and its nucleotide sequence is shown in SEQ ID NO.3; (3) inserting a DAS+4 degradation tag after the lpdA gene of the pyruvate dehydrogenase complex; the coding sequence of the DAS+4 degradation tag is shown in SEQ ID NO.
2.
5. The method according to claim 4, characterized in that The reducing the expression of phosphotransacetylase includes but is not limited to knocking out the phosphotransacetylase encoding gene eutD.
6. The method according to claim 5, characterized in that The recombinant Escherichia coli having the ability to produce L-alanine includes but is not limited to Escherichia coli B0016-060BC.
7. The method according to any one of claims 4 to 6, characterized in that: The nucleotide sequence of gene eutD is shown in Gene ID: 946940; the nucleotide sequence of gene mgsA is shown in Gene ID: 945574; and the nucleotide sequence of gene lpdA is shown in Gene ID: 944854.
8. A method for producing L-alanine by fermentation, characterized in that: The recombinant Escherichia coli according to any one of claims 1 to 3 is cultured in an M9 medium containing glucose and ammonium sulfate in an aerobic-oxygen-limited two-stage fermentation.
9. The method according to claim 8, characterized in that The aerobic-oxygen-limited two-stage fermentation culture is fermented under the conditions of (a) or (b): (a) During the aerobic fermentation stage, the fermentation temperature was controlled at 32-34°C and cultured until OD 600 When the temperature reaches 3.0, it turns to the oxygen-limited fermentation stage; the oxygen-limited fermentation stage is statically cultured at 40-42° C., and glucose is also fed into the culture system during this stage; (b) During the aerobic fermentation stage, the fermentation temperature was controlled at 32-34°C and the dissolved oxygen was ≥45%. The culture was continued until the OD 600 When the temperature reaches 50, the culture is continued at 40-42° C. for 40-50 min and then the fermentation is switched to the oxygen-limited fermentation stage; in the oxygen-limited fermentation stage, the air flux is adjusted to 0 and the fermentation temperature is 40-42° C. In this stage, glucose is also fed into the culture system and the glucose concentration is controlled to be ≥10 g / L.
10. Use of the recombinant Escherichia coli according to any one of claims 1 to 3 or the method according to any one of claims 8 to 9 in producing L-alanine or a product containing L-alanine.
Citation Information
Patent Citations
Escherichia coli for efficiently producing L-alanine by fermentation
CN104774790A
Recombinant escherichia coli with high yield of L-homoserine as well as construction method and application of recombinant escherichia coli
CN116622607A
Escherichia coli recombinant bacterium construction method and application of high-yield L-alanine
CN117736948A
Engineering bacteria for producing DL-alanine and method for producing DL-alanine by using engineering bacteria
US20150247174A1
Cited By
Method for efficiently synthesizing L-alanine by strengthening microbial carbon metabolic flow under anaerobic condition
CN122214228A
